Trial Profile
Comparison of the Efficiency of Two Different PPI Formula in Treatment of Atypical GERD Patients, a Randomized Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 May 2020
Price :
$35
*
At a glance
- Drugs Dexlansoprazole (Primary) ; Lansoprazole
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 13 May 2020 Status changed from recruiting to completed.
- 13 May 2020 Primary endpoint (The response rate of atypical GERD symptom) has been met according to the results published in the Journal of Gastroenterology and Hepatology
- 13 May 2020 Results published in the Journal of Gastroenterology and Hepatology